| 000 | 01693 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514183443.0 | ||
| 264 | 0 | _c20041110 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0141-9854 | ||
| 024 | 7 |
_a10.1111/j.1365-2257.2004.00591.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZimmer, J | |
| 245 | 0 | 0 |
_aCurrent management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. _h[electronic resource] |
| 260 |
_bClinical and laboratory haematology _cApr 2004 |
||
| 300 |
_a137-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDanazol _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHemorrhage _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSplenectomy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAndrès, E | |
| 700 | 1 | _aNoel, E | |
| 700 | 1 | _aKoumarianou, A | |
| 700 | 1 | _aBlicklé, J-F | |
| 700 | 1 | _aMaloisel, F | |
| 773 | 0 |
_tClinical and laboratory haematology _gvol. 26 _gno. 2 _gp. 137-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2257.2004.00591.x _zAvailable from publisher's website |
| 999 |
_c14770230 _d14770230 |
||